AstraZeneca Resumes Clinical Study of its COVID-19 Vaccine in Japan

 AstraZeneca Resumes Clinical Study of its COVID-19 Vaccine in Japan

Shots:

  • The P-I/II study of AZD1222 has resumed in Japan following the discussion with the PMDA. Additionally, the company is in talks with the US FDA to facilitate review of the information needed to decide regarding the resumption of the US trial
  • A standard review process triggered a voluntary pause to vaccination across all global trials on Sept 06, 2020, to allow the review of safety data by an independent committee
  • The resumption follows the restart of clinical study in the UK, Brazil, South Africa, and India

Click here ­to­ read full press release/ article | Ref: AstraZeneca | Image: Mint

Related News: AstraZeneca Resumes COVID-19 Vaccine Trials in the UK

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post